Last reviewed · How we verify
Poison
At a glance
| Generic name | Poison |
|---|---|
| Also known as | different poisonous materials |
| Sponsor | MTI University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH Project)
- Lock and Protect: Reducing Adolescent Access to Lethal Means of Suicide (NA)
- Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment (NA)
- Causality of Poisoning of the Elderly: Prospective Study Based on Data From the Poison Control Centre of Bordeaux
- Behavioural Skills Training (BST) for Teaching Sexual Abuse Prevention Skills for Children with Intellectual Disabilities (NA)
- Functional Appliance for Orthognathic Surgery (NA)
- Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD (PHASE2, PHASE3)
- Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Poison CI brief — competitive landscape report
- Poison updates RSS · CI watch RSS
- MTI University portfolio CI